SIS
PPH icon

Sound Income Strategies’s VanEck Pharmaceutical ETF PPH Stock Holding History

Sound Income Strategies’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-143
Closed -$15K – 1881
2026
Q1 		$15K Hold
143
– – ﹤0.01% 1314
2025
Q4 		$15.1K Buy
+143
New +$13.9K ﹤0.01% 1271
2024
Q3 		– Sell
-11
Closed -$1.01K – 1472
2024
Q2 		$1.01K Buy
+11
New +$982 ﹤0.01% 1203

Other funds holding PPH

AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
RBC
Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
CWRP
Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AWA
ARQ Wealth Advisors Scottsdale, Arizona $807M AUM 19.58% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Sound Income Strategies's PPH Position: Q2 2026 in Review

Sound Income Strategies sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2026, closing a stake of 143 shares — an estimated $15K sold.

Sound Income Strategies first reported a position in PPH in Q2 2024 and held it in 3 quarters. The position peaked at $15.1K in Q4 2025. 47 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Sound Income Strategies reported no remaining VanEck Pharmaceutical ETF position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 143 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $15K.
  • Sound Income Strategies first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and held it in 3 quarters.
  • Sound Income Strategies's VanEck Pharmaceutical ETF position peaked at $15.1K in Q4 2025.
  • 47 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.